After a delivery prompted by severe preeclampsia at 33 weeks, the immediate crisis can dominate the team’s attention. But an important question remains: what follow-up needs to travel with the patient after discharge? In this case, severe-range hypertension and pulmonary edema make a clear postpartum and primary-care handoff especially important.
The case does not provide her postpartum blood pressure, follow-up laboratory results, or medication plan. Do not assume that blood pressure or organ findings have normalized. At 33 weeks, the episode also falls before the commonly used 34-week boundary for early-onset preeclampsia; that makes future-risk counseling relevant, but it does not determine what will happen to this individual.
Make the first handoff about blood pressure—and ownership
Arrange blood-pressure evaluation after birth rather than relying only on a routine postpartum visit. Evaluation should occur no later than 7–10 days postpartum for people with hypertensive disorders of pregnancy; those with severe hypertension should be evaluated within 72 hours. Specify who will check the pressure, when the check will happen, and how the patient can reach the team if readings or symptoms are concerning.
Preeclampsia can also present after delivery, including up to 6 weeks postpartum. A persistent headache, visual changes, shortness of breath, chest pain, upper-abdominal pain, or a severe-range blood pressure (systolic pressure of at least 160 mm Hg or diastolic pressure of at least 110 mm Hg) calls for prompt assessment—not a wait for the scheduled visit. For this patient, document the pulmonary edema and make clear that new or persistent breathing symptoms need evaluation rather than automatic attribution to recovery.
The discharge record should preserve the details that a later clinician cannot infer from “preeclampsia” alone: gestational age at onset and delivery; severe features, including neurologic symptoms and pulmonary edema; the blood-pressure course; antihypertensive medications and follow-up instructions; and whether abnormal platelet, liver, kidney, or urine-protein results were reassessed. If results or the medication plan are not yet known, say so and assign follow-up.
Treat the pregnancy as a risk signal, not a prediction
A history of preeclampsia—particularly when it leads to preterm birth—is associated with greater later risk of chronic hypertension and cardiovascular and kidney disease. That is a reason to preserve the history and assess conventional risk factors over time. It is not proof that the patient currently has cardiovascular disease or will develop it.
| What to carry forward | What not to conclude |
|---|---|
| Preeclampsia at 33 weeks, with severe features and pulmonary edema | That the patient has chronic hypertension or heart disease now |
| A higher long-term risk of cardiovascular and kidney disease | A precise individual outcome or timeline |
| Increased risk of preeclampsia in a future pregnancy | That recurrence is inevitable or accurately summarized by one percentage |
At follow-up, review whether hypertension persists and assess cardiovascular risk in the context of the patient’s overall history. Arrange a comprehensive postpartum assessment by 12 weeks, with early symptom follow-up, screening and management of cardiovascular risk factors, and transition to longitudinal preventive care during the first postpartum year. Blood pressure, glycemia, lipids, obesity, tobacco exposure, and other established risk factors may be relevant; testing and management should be individualized. Evidence does not establish one universal schedule of advanced cardiac tests for every asymptomatic patient after preeclampsia. Persistent hypertension, ongoing symptoms, or abnormal findings may warrant additional evaluation or referral.
A useful explanation is direct but not deterministic: “This pregnancy complication makes future blood pressure and heart health worth following more deliberately. It does not mean you have heart disease now. We’ll make sure your primary-care team knows what happened and agrees on follow-up.”
Use the next pregnancy plan before pregnancy begins
For future counseling, avoid turning a recurrence statistic into a personal forecast. Risk depends on factors such as the timing and outcome of the prior pregnancy and the patient’s health before the next one. Explain that a prior episode raises risk, while acknowledging that no single percentage can reliably predict an individual’s outcome from the details provided here.
The history should prompt preconception review: check blood pressure and relevant metabolic or kidney conditions, review medications, and make a plan for early prenatal care. In a future pregnancy, a history of preeclampsia—especially with an adverse outcome—is a high-risk factor for which low-dose aspirin prophylaxis is recommended when appropriate. The recommended dose is 81 mg daily, started between 12 and 28 weeks (optimally before 16 weeks) and continued until delivery. Review contraindications and the plan with the obstetric clinician; aspirin reduces risk but does not guarantee that preeclampsia will not recur.
Practical takeaways
- Arrange postpartum blood-pressure follow-up and identify who is responsible for it; do not leave the plan implicit.
- Record the timing, severe features, pulmonary edema, blood-pressure course, medications, and any pending follow-up results.
- Explain that early-onset preeclampsia is associated with higher future cardiovascular and kidney risk, not a diagnosis or a personal prediction.
- Transfer the pregnancy history to primary care, arrange comprehensive postpartum assessment by 12 weeks, and plan longitudinal risk-factor follow-up during the first year.
- For a future pregnancy, plan early care and discuss 81-mg aspirin prophylaxis at the recommended gestational timing, if appropriate.
